title: Hypoxic initiation of pulmonary hypertension is mediated by serotonin secretion from neuroepithelial bodies in chemodenervated dogs.
abstract: The purpose of this study was to investigate the stimulatory effect of hypoxia on the secretion of serotonin by neuroepithelial bodies (NEB) as well as to determine the relation between its level and changes in pulmonary arterial pressure (PAP) and also to determinate the effect of serotonin antagonists (pizotifen and methysergide) on the responses of pulmonary and systemic arterial pressures. The experiments were carried out in peripheral chemoreceptor-denervated dogs anesthetized with Na penthabarbital (30 mg/kg i.v.). On the breathing of normoxic and hypoxic (7% O2-93% N2) gas mixtures and on the injection of KCN (80 microg/kg i.v.), PAP, systemic arterial blood pressure (BP), tidal volume (VT), respiratory frequency (f/min), ventilation minute volume (VE) were determined. Also PAP and BP were recorded before and after the injection of pizotifen (0.5 mg/kg i.v.) and methysergide (1 mg/kg i.v.) during normoxic or hypoxic gas mixture breathing. At the end of each experimantal phase, serotonin level, PaO2, PaCO2 and pHa values in blood samples obtained from left ventricle and femoral artery were determined. On the breathing of the hypoxic gas mixture of the chemodenervated dogs, VT, VE and BP significantly decreased (P < 0.001, P < 0.001, P < 0.01). The mean value of PAP and serotonin levels (ventricular and femoral) were found significantly increased when compared with the corresponding normoxic values (P < 0.001, P < 0.05). On the other hand, injection of KCN produced no significant changes in PAP, serotonin levels, BP and respiratory parameters. After the injection of pizotifen, PAP was significantly increased in hypoxia (P < 0.01). After the injection of methysergide, the response of PAP was completely abolished during the breathing of hypoxic gas mixture. The finding of the abolition of response of PAP to hypoxia after the injection of methysergide indicates that serotonin release from NEB may be responsible for the elevation of PAP in hypoxic hypoxia.
authors.affiliation: Department of Physiology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey. nermink@Istanbul.edu.tr
authors.forename: Nermin Karaturan
authors.initials: NK
authors.lastname: Yelmen
authors.forename: Gülderen
authors.initials: G
authors.lastname: Sahin
authors.forename: Tulin
authors.initials: T
authors.lastname: Oruç
authors.forename: Münire
authors.initials: M
authors.lastname: Hacibekiroğlu
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002245:Carbon Dioxide / Q000097:blood; D002344:Carotid Body / Q000378:metabolism*; D004285:Dogs; D006863:Hydrogen-Ion Concentration; D006976:Hypertension, Pulmonary / Q000209:etiology* / Q000378:metabolism*; D000860:Hypoxia / Q000150:complications* / Q000378:metabolism*; D008784:Methysergide / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010918:Pizotyline / Q000494:pharmacology; D011669:Pulmonary Wedge Pressure / Q000187:drug effects / Q000502:physiology; D015656:Respiratory Mechanics; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology
chemical_list: D012702:Serotonin Antagonists; D010918:Pizotyline; D002245:Carbon Dioxide; D012701:Serotonin; D010100:Oxygen; D008784:Methysergide